Back to the Top
Provides unprecedented access to detailed drug pharmacokinetics data and over 1,000,000
extracted exposure observations from the FDA and EMEA documents on more than 2,100
New York, NY, 14 September, 2010 - Elsevier today announces that it has significantly increased its service offering to pharmaceutical R&D professionals with the launch of a new Pharmacokinetics Module of PharmaPendium(TM), the online resource for authoritative drug development data. The Pharmacokinetics Module allows pharmacokineticists (and related professionals in regulatory affairs, preclinical, safety pharmacology, etc.) to access multiple exposure parameter measurements under various experimental conditions for over 2,100 drugs, enabling the retrieval and analysis of over 1,000,000 pharmacokinetic observations. "The new Pharmacokinetics Module is not only a faster and more efficient way to search pharmacokinetics data, it is the only place to find this level of comparative exposure information, great for modeling and comparing therapeutic windows earlier in the development process", said Philip MacLaughlin, Senior Product Manager at Elsevier. "This is a level of information that stands
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "PHARMAPENDIUM(TM) Launches Pharmacokinetics Module" as the subject
Support PharmPK by using the
Copyright 1995-2011 David W. A. Bourne (email@example.com)